1Arakaki R, Yamasaki T, Kanno T, et al. 22.CCL2 as a potential therapeutic target for clear cell renal cell carcinoma. Cancer Med. 2016; 5: 2920–2933.
2Vasudev NS, Selby PJ, Banks RE. 23.Renal cancer biomarkers: the promise of personalized care. Bmc Med. 2012; 10: 112.
3Zhu X, Liang J, Shrubsole MJ, et al. Calcium intake and ion transporter genetic polymorphisms interact in human colorectal neoplasia risk in a 2-phase study. The Journal of nutrition. 2014; 144: 1734–1741.
4He Y, Zhang P, Zhang D, et al. Combined assessment of low PGRMC1/positive ATP1A1 levels has enhanced prognostic value for renal cell carcinoma. Oncol Rep. 2018; 40: 1467–1476.
5Lin CS, Lee HT, Lee MH, et al. Role of Mitochondrial DNA Copy Number Alteration in Human Renal Cell Carcinoma. Int J Mol Sci. 2016; 17.
6Edgar R, Domrachev M, Lash AE. 6.Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002; 30: 207–210.
7Lenburg ME, Liou LS, Gerry NP, Frampton GM, Cohen HT, Christman MF. 7.Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. Bmc Cancer. 2003; 3: 31.
8Gumz ML, Zou H, Kreinest PA, et al. 8.Secreted Frizzled-Related Protein 1 Loss Contributes to Tumor Phenotype of Clear Cell Renal Cell Carcinoma. Clin Cancer Res. 2007; 13: 4740–4749.
9Gerlinger M, Horswell S, Larkin J, et al. 9.Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet. 2014; 46: 225–233.
10Thibodeau BJPD, Fulton MMD, Fortier LEMS, et al. 10.Characterization of clear cell renal cell carcinoma by gene expression profiling. Urologic Oncology: Seminars and Original Investigations. 2015; 34: 161–168.
11Huang DW, Sherman BT, Tan Q, et al. 11.The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007; 8: R183.
12Kanehisa M. 12.The KEGG database. Novartis Found Symp. 2002; 247: 91–101, 101–103, 119–128, 244–252.
13Ashburner M, Ball CA, Blake JA, et al. 13.Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25: 25–29.
14Szklarczyk D, Gable AL, Lyon D, et al. 14.STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019; 47: D607-D613.
15Van Parys T, Melckenbeeck I, Houbraken M, et al. 15.A Cytoscape app for motif enumeration with ISMAGS. Bioinformatics. 2017; 33: 461–463.
16Bader GD, Hogue CW. 16.An automated method for finding molecular complexes in large protein interaction networks. Bmc Bioinformatics. 2003; 4: 2.
17Gao J, Aksoy BA, Dogrusoz U, et al. 17.Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013; 6: l1.
18Cerami E, Gao J, Dogrusoz U, et al. 18.The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2: 401–404.
19Maere S, Heymans K, Kuiper M. 19.BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics (Oxford, England). 2005; 21: 3448–3449.
20Haeussler M, Zweig AS, Tyner C, et al. 20.The UCSC Genome Browser database: 2019 update. Nucleic Acids Res. 2019; 47: D853-D858.
21Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. 21.GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45: W98-W102.
22Cardaci S, Zheng L, MacKay G, et al. 28.Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis. Nat Cell Biol. 2015; 17: 1317–1326.
23Liu Y, Li W, Duan Y. 29.Effect of H2O2 induced oxidative stress (OS) on volatile organic compounds (VOCs) and intracellular metabolism in MCF–7 breast cancer cells. J Breath Res. 2019; 13: 36005.
24Grange C, Brossa A, Bussolati B. 30.Extracellular Vesicles and Carried miRNAs in the Progression of Renal Cell Carcinoma. Int J Mol Sci. 2019; 20: 1832.
25Grabmaier K, A DWM, Verhaegh GW, Schalken JA, Oosterwijk E. 31.Strict regulation of CAIX(G250/MN) by HIF–1alpha in clear cell renal cell carcinoma. Oncogene. 2004; 23: 5624–5631.
26Woodard J, Sassano A, Hay N, Platanias LC. 32.Statin-Dependent Suppression of the Akt/Mammalian Target of Rapamycin Signaling Cascade and Programmed Cell Death 4 Up-Regulation in Renal Cell Carcinoma. Clin Cancer Res. 2008; 14: 4640–4649.
27Wilson MR, Hou Z, Wilson LJ, Ye J, Matherly LH. 33.Functional and mechanistic roles of the human proton-coupled folate transporter transmembrane domain 6–7 linker. Biochem J. 2016; 473: 3545–3562.
28Zhao J, Li J, Fan TWM, Hou SX. Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells. Oncotarget. 2017; 8: 83602.
29Luo S, Li Y, Ma R, et al. Downregulation of PCK2 remodels tricarboxylic acid cycle in tumor-repopulating cells of melanoma. Oncogene. 2017; 36: 3609–3617.
30Liu M, Jin L, Sun S, et al. Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma. Oncogene. 2018; 37: 1637–1653.
31Leithner K, Hrzenjak A, Trötzmüller M, et al. PCK2 activation mediates an adaptive response to glucose depletion in lung cancer. Oncogene. 2015; 34: 1044–1050.
32Vincent EE, Sergushichev A, Griss T, et al. Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth. Mol Cell. 2015; 60: 195–207.
33Zhang WC, Shyh-Chang N, Yang H, et al. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell. 2012; 148: 259–272.
34Jäger K, Larribère L, Wu H, Weiss C, Gebhardt C, Utikal J. Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis. Cancers. 2019; 11: 76.
35Min HL, Kim J, Kim WH, Jang BG, Kim MA. Epigenetic Silencing of the Putative Tumor Suppressor Gene GLDC (Glycine Dehydrogenase) in Gastric Carcinoma. Anticancer Res. 2016; 36: 179.